Alpha-1-antitrypsin phenotypes in adult liver disease patients

Upsala Journal of Medical Sciences

Volumn 114, Issue 4, 2009, Pages 228-234

  Topic, Aleksandra ^a   Alempijevic, Tamara ^b   Milutinovic, Aleksandra Sokic ^b   Kovacevic, Nada ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Adults; Alpha 1 antitrypsin; Liver disease; Phenotypes

Indexed keywords

ALPHA 1 ANTITRYPSIN; SERPINA1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TUMOR; MALE; MIDDLE AGED; PHENOTYPE;

ADULT; AGED; ALLELES; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; AMINO ACID SUBSTITUTION; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 72449131405     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009730903243472     Document Type: Article

References (30)

1. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168:818-900.
2. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha1-antitrypsin deficiency. N Engl J Med. 1986;314:736-739
3. Curiel DT, Chytil A, Courtney M, Crystal RG. Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264!Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion. J Biol Chem. 1989;264:10477-10486
4. Elliott PR, Stein PE, Bilton D, Carrell RW, Lomas DA. Structural explanation for the deficiency of S a1-antitrypsin. Nat Struct Biol. 1996;3:910-911
5. Mahadeva R, Chang WS, Dafforn TR, Oakley DJ, Foreman RC, Calvin J, et al. Heteropolymerization of S, I, and Z a1-antitrypsin and liver cirrhosis. J Clin Invest. 1999;103:999-1006.
6. Tobin MJ, Cook PJ, Hutchinson DC. Alpha 1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z: A survey by the British Thoracic Association. Br J Dis Chest. 1983;77:14-27.
7. Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis. 1988;138:327-336
8. Kishimoto Y, Yamada S, Hirayama C. An association between AAT phenotype and chronic liver disease. Hum Genet. 1990;84:132-136
9. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976;294:1316-1321
10. Topic A, Jelic Ivanovic Z, Spasojevic Kalimanovska V, Spasic S, Stankovic I. Distribution of alpha-1-antitrypsin phenotypes in Serbian newborns and children with liver disease. Acta Paediatrica. 2002;91:726-727
11. Cottrall K, Cook PJL, Mowat AP. Neonatal hepatitis syndrome and alpha-1-antitrypsin deficiency: An epidemiological study in South-East England. Postgrad Med J. 1974;50:376-380
12. Deutsch J, Smith AL, Danks DM, Campbell PE. Long term prognosis for babies with neonatal liver disease. Arch Dis Child. 1985;60:447-451
13. Mowat AP, Psacharopoulos HT, Williams R. Extrahepatic biliary atresia versus neonatal hepatitis. Review of 137 prospectively investigated infants. Arch Dis Child. 1976;51:763-770
14. Odièvre M, Hadchouel M, Landrieu P, Alagille D, Eliot N. Long-term prognosis for infants with intrahepatic cholestasis and patent extrahepatic biliary tract. Arch Dis Child. 1981;56:373-376
15. Adrian-Casavilla F, Reyes J, Tzakis A, Wright HI, Gavaler JS, Lendoire J, et al. Liver transplantation for neonatal hepatitis as compared to the other two leading indications for liver transplantation in children. J Hepatol. 1994;21:1035-1039
16. Esquivel CO, Iwatsuki S, Gordon RD, Marsh WW Jr, Koneru B, Makowka L, et al. Indications for pediatric liver transplantation. J Pediatr. 1987;111:1039-1045
17. Kok KF, Wahab PJ, Houwen RH, Drenth JP, De Man RA, Van Hoek B, et al. Heterozygous alpha-1 antitrypsin deficiency as a co-factor in the development of chronic liver disease: A review. Neth J Med. 2007;65:160-166
18. Elzouki AN, Eriksson S. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?. Eur J Gastroenterol Hepatol. 1996;8:989-994
19. Hashemi M, Alavian SM, Ghavami S, De Serres FJ, Salehi M, Doroudi T, et al. High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol Res. 2005;33:292-297
20. Eigenbrodt ML, McCashland TM, Dy RM, Clark J, Galati J. Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease. Am J Gastroenterol. 1997;92:602-607
21. Fischer HP, Ortiz-Pallardo ME, Ko Y, Esch C, Zhou H. Chronic liver disease in heterozygous alpha1-antitrypsin deficiency PiZ. J Hepatol. 2000;33:883-892
22. Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. Hepatology. 1998;28:1058-1063
23. Serfaty L, Chazouilleres O, Poujol-Robert A, Morand-Joubert L, Dubois C, Chretien Y, et al. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology. 1997;26:776-779
24. Vecchio FM, Fabiano A, Orsini G, Ragusa D, Massi G. Alpha- 1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults. Digestion. 1983;27:100-104
25. Regev A, Guaqueta C, Molina EG, Conrad A, Mishra V, Brantly ML, et al. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. J Pediatr Gastroenterol Nutr. 2006;43:30-35
26. Scott BB, Egner W. Does alpha1-antitrypsin phenotype PiMZ increase the risk of fibrosis in liver disease due to hepatitis C virus infection? Eur J Gastroenterol Hepatol. 2006;18:521-523
27. Bassett ML, Bradbear RA, Kerlin P, Clark P. a1-Antitrypsin phenotypes in chronic active hepatitis. J Gastroenterol Hepatol. 1986;1:207-211
28. Rakela J, Goldschmiedt M, Ludwig J. Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency. Dig Dis Sci. 1987;32:1358-1362
29. Vogel W, Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H. Causes of liver disease in an adult population with heterozygous and homozygous alpha 1-antitrypsin deficiency. Acta Paediatr Suppl. 1994;393:24-26
30. Bowlus CL, Willner I, Zern MA, Reuben A, Chen P, Holladay B, et al. Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin Gastroenterol Hepatol. 2005;3:390-396